Speaking from Servier’s new open-plan office in Lisbon, a space aimed at promoting cross-functional integration and “collective intelligence,”…

France's life sciences industry is falling behind its European neighbours, its growth deeply hampered, the French life sciences think tank G5 Santé…

Servier Morocco, with its robust portfolio of 15 products and a turnover of EUR 30 million, has forged a leading position in the local market.…

The latest news from French healthcare and pharma, including an update on the hospital crisis; MaaT Pharma and Skyepharma's new cGMP microbiome…

Encircled by heavyweight life sciences powerhouses of the likes of Germany, France and Switzerland, plucky Belgium nonetheless continues to astonish…

Pierre Boyer, GM at Servier BeLux for the past six years, outlines the unique characteristics and challenges of the Belgian market and shares the…

French mid-cap Servier has launched a new visual identity and logo and announced an ambitious 2030 growth plan with an increased focus on…

The top ten pharma companies in France for 2021. Sanofi leads the pack with EUR 2.367 billion in turnover, followed by Servier (EUR 2.284 billion) and…

Servier's Estève Speranza outlines the rationale behind the French group's reorganisation in the Nordic countries, how the global shift towards…

Barbara Fritsche-Surchat outlines Servier's historic commitment to Switzerland, how the French mid-cap's global oncology pivot is translating into its…

The Top 10 pharma companies in the EUR 28.9 million French pharma market in 2019. Homegrown players Sanofi and Servier lead the way, followed by…

The latest from French pharma where Sanofi has inked a deal to produce 125 million doses of Pfizer’s COVID-19 vaccine as it faces delays with its…